Total submissions: 25
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000190557 | SCV000051567 | benign | Hypertrophic cardiomyopathy | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000035689 | SCV000059340 | benign | not specified | 2010-07-08 | criteria provided, single submitter | clinical testing | The Arg326Gln variant is thought to be a common variant found in over 5% of indi viduals from certain populations (Jaaskelainen et al. 2002, dbSNP rs34580786). T herefore, it is highly unlikely that this variant is disease-causing. |
Gene |
RCV000035689 | SCV000170458 | benign | not specified | 2012-06-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000190557 | SCV000252659 | benign | Hypertrophic cardiomyopathy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000238837 | SCV000296898 | benign | Dilated cardiomyopathy 1A | 2015-10-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000250801 | SCV000317754 | benign | Cardiovascular phenotype | 2017-08-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586999 | SCV000696336 | benign | not provided | 2016-06-06 | criteria provided, single submitter | clinical testing | Variant summary: The MYBPC3 c.977G>A (p.Arg326Gln) variant involves the alteration of a conserved nucleotide. 2/4 in silico tools predict a benign outcome (SNPs&GO not captured due to low reliability index). This variant was found in 521/94034 control chromosomes (3 homozygotes), predominantly observed in the European (Finnish) subpopulation at a frequency of 0.015543 (77/4954). This frequency is about 16 times the estimated maximal expected allele frequency of a pathogenic MYBPC3 variant (0.0010005), suggesting this is likely a benign polymorphism found primarily in the populations of European (Finnish) origin. In addition, the variant was found to co-occur with a pathogenic MYBPC3 variant (Gln1233Ter) in two individuals (Ingles_JMG_2005 and internal LCA data), and was also found in an unaffected sister of an HCM patient (Jaaskelainen_JMM_2002). Furthermore, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Taken together, this variant is classified as benign. |
Genome Diagnostics Laboratory, |
RCV000613127 | SCV000743565 | benign | Hypertrophic cardiomyopathy 4 | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000613127 | SCV000744858 | benign | Hypertrophic cardiomyopathy 4 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000035689 | SCV000747987 | likely benign | not specified | 2016-10-26 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000776079 | SCV000910815 | benign | Cardiomyopathy | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852653 | SCV000995358 | likely benign | Primary dilated cardiomyopathy; Premature ventricular contraction | 2019-03-25 | criteria provided, single submitter | clinical testing | |
Agnes Ginges Centre for Molecular Cardiology, |
RCV000190557 | SCV000996360 | benign | Hypertrophic cardiomyopathy | 2017-09-22 | criteria provided, single submitter | research | This variant has been identified as part of our research program. Refer to the 'condition' field for the phenotype of the proband(s) identified with this variant. For further information please feel free to contact us. |
Ce |
RCV000586999 | SCV001148280 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | MYBPC3: BS2 |
Illumina Laboratory Services, |
RCV000613127 | SCV001263316 | likely benign | Hypertrophic cardiomyopathy 4 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001107678 | SCV001264853 | benign | Left ventricular noncompaction 10 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Fulgent Genetics, |
RCV002496538 | SCV002805377 | likely benign | Hypertrophic cardiomyopathy 4; Left ventricular noncompaction 10 | 2021-08-26 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000586999 | SCV004563090 | benign | not provided | 2023-10-09 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000190557 | SCV004834696 | benign | Hypertrophic cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000157304 | SCV000207036 | likely benign | Primary familial hypertrophic cardiomyopathy | 2014-05-16 | no assertion criteria provided | clinical testing | |
Blueprint Genetics | RCV000157305 | SCV000207037 | likely benign | Primary dilated cardiomyopathy | 2014-05-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000613127 | SCV000733056 | benign | Hypertrophic cardiomyopathy 4 | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000035689 | SCV001919629 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000035689 | SCV001955481 | benign | not specified | no assertion criteria provided | clinical testing | ||
Cohesion Phenomics | RCV000190557 | SCV003800601 | benign | Hypertrophic cardiomyopathy | 2022-10-10 | no assertion criteria provided | clinical testing |